Skip to search formSkip to main contentSkip to account menu

Delavirdine Mesylate

Known as: Delavirdine Mesylate [Chemical/Ingredient], Mesylate, Delavirdine 
A mesylate salt form of delavirdine, a synthetic, non-nucleoside reverse transcriptase inhibitor. In combination with other anti-retroviral drugs… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
  • P. Gao
  • Pharmaceutical Research
  • 2004
  • Corpus ID: 6122113
AbstractPurpose. The application of solid-state nuclear magnetic resonance for the quantitation of relative amounts of… 
Review
2002
Review
2002
Rifampin is a potent inducer of cytochrome P-450 oxidative enzymes. A few examples of well-documented clinically significant… 
1999
1999
To evaluate the antiretroviral activity of delavirdine mesylate, a non-nucleoside reverse transcriptase inhibitor of HIV-1, we… 
Highly Cited
1998
Highly Cited
1998
Administration of delavirdine, an HIV-1 reverse transcriptase inhibitor, to rats or monkeys resulted in apparent loss of hepatic… 
1998
1998
The potential pharmacokinetic drug-drug interaction between delavirdine, a nonnucleoside analogue reverse transcriptase inhibitor… 
Highly Cited
1997
Highly Cited
1997
1997
1997
Delavirdine is a nonnucleoside reverse transcriptase inhibitor with in vitro activity against human immunodeficiency virus type 1… 
Highly Cited
1997
Review
1996
Review
1996
  • W. Freimuth
  • Advances in experimental medicine and biology
  • 1996
  • Corpus ID: 44512677
In summary, DLV has been well-tolerated in > 1,000 HIV-1 infected patients. Skin rash is the most prevalent medical event… 
Highly Cited
1996
Highly Cited
1996
Delavirdine mesylate (DLV) is a potent nonnucleoside reverse transcriptase inhibitor with activity specific for human…